ArticleRSC advances2026
Sahara Desert sand "Chitligsan": characterisation and assessment of antibacterial activity and cytotoxicity.
Article in RSC advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Antimicrobial resistance presents a significant global health concern, rendering antimicrobial therapies less effective and complicating the management of infectious diseases. To address this challenge, the utilisation of natural alternatives, particularly metal oxide-based nanomaterials, has emerged as a promising strategy due to their antimicrobial activity and favourable physicochemical properties, without inducing antimicrobial resistance. In this study, Chitligsan, a naturally occurring hybrid compound extracted from the sand of the Sahara Desert, was characterised and evaluated in terms of its antimicrobial activity and biocompatibility. The elemental and mineral composition of Chitligsan was investigated using FTIR, SEM-EDS, XRF, XRD, and Py-GC-MS analyses. The results indicated the presence of diverse metal oxide compounds, including Fe
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.